Table 1 Characteristics of the study population, including the frequency of sensitization to animal allergen components in the research group
From: Analysis of feline and canine allergen components in patients sensitized to pets
Features | Study group, n = 70 | |
|---|---|---|
Gender | Male-28 | Female-42 |
Age (mean, min. and max. value) | 35.5; 18–65 | |
33.3; 19–65 | 37; 18–65 | |
Concentration of total IgE (mean, min. and max. value) in kU/l | 806.3; 7.44–5375 | |
502.4; 7.44–5000 | 1008.9; 13–5375 | |
Canine allergen components: number of patients with allergen-specific IgE levels exceeding 0.35 kU/l | ||
|---|---|---|
Can f 1 (lipocalin) | 28 (40% of the study group) | |
7 (25% of male) | 21 (50% of female) | |
Can f 2 (lipocalin) | 10 (14.3% of the study group) | |
1 (3.6% of male) | 9 (21.4% of female) | |
Can f 3 (albumin) | 16 (22.9% of the study group) | |
6 (21.4% of male) | 10 (23.8% of female) | |
Can f 5 (prostate gland - kallikrein) | 22 (31.4% of the study group) | |
7 (25% of male) | 16 (38.1% of female) | |
Feline allergen components: number of patients with allergen-specific IgE levels exceeding 0.35 kU/l | ||
|---|---|---|
Fel d 1 (secretoglobin, a uteroglobin-like protein) | 61 (87.1% of the study group) | |
27 (96.4% of male) | 35 (83.3% of female) | |
Fel d 2 (albumin) | 16 (22.9% of the study group) | |
6 (21% of male) | 10 (23.8% of female) | |
Fel d 4 (lipocalin) | 32 (45.7% of the study group) | |
10 (35.7% of male) | 22 (52.4% of female) | |